How to Trip Rapid Review

Step 1: Select articles relevant to your search (remember the system is only optimised for single intervention studies)

Step 2: press

Step 3: review the result, and maybe amend the or if you know better! If we're unsure of the overall sentiment of the trial we will display the conclusion under the article title. We then require you to tell us what the correct sentiment is.

3,698 results for

Hamilton Anxiety Scale

by
...
Latest & greatest
Alerts

Export results

Use check boxes to select individual results below

SmartSearch available

Trip's SmartSearch engine has discovered connected searches & results. Click to show

1. Psychometric Properties of the Reconstructed Hamilton Depression and Anxiety Scales Full Text available with Trip Pro

Psychometric Properties of the Reconstructed Hamilton Depression and Anxiety Scales Although widely used, the Hamilton Rating Scale for Depression (HRSD) and Hamilton Anxiety Rating Scale (HARS) discriminate poorly between depression and anxiety. To address this problem, Riskind, Beck, Brown, and Steer (J Nerv Ment Dis. 175:474-479, 1987) created the Reconstructed Hamilton Scales by reconfiguring HRSD and HARS items into modified scales. To further analyze the reconstructed scales, we examined (...) their factor structure and criterion-related validity in a sample of patients with major depressive disorder and no comorbid anxiety disorders (n = 215) or with panic disorder and no comorbid mood disorders (n = 149). Factor analysis results were largely consistent with those of Riskind et al. The correlation between the new reconstructed scales was small. Compared with the original scales, the new reconstructed scales correlated more strongly with diagnosis in the expected direction. The findings

2017 The Journal of nervous and mental disease

2. Hamilton Anxiety Scale

Hamilton Anxiety Scale Hamilton Anxiety Scale Toggle navigation Brain Head & Neck Chest Endocrine Abdomen Musculoskeletal Skin Infectious Disease Hematology & Oncology Cohorts Diagnostics Emergency Findings Procedures Prevention & Management Pharmacy Resuscitation Trauma Emergency Procedures Ultrasound Cardiovascular Emergencies Lung Emergencies Infectious Disease Pediatrics Neurologic Emergencies Skin Exposure Miscellaneous Abuse Cancer Administration 4 Hamilton Anxiety Scale Hamilton Anxiety (...) Scale Aka: Hamilton Anxiety Scale , HAM-A II. Background Authored by Max Hamilton in 1959 Public domain anxiety rating scale III. Criteria: Symptom Rating Scale (0=Not Present, 4=Disabling) Anxious Mood Worries Anticipates worst Tension Startles Cries easily Restless Trembling Fears Fear of the dark Fear of strangers Fear of being alone Fear of animal Difficulty falling asleep or staying asleep Difficulty with s Intellectual Poor concentration Memory Depressed Mood Decreased interest in activities

2018 FP Notebook

3. The Major Depressive Disorder Hierarchy: Rasch Analysis of 6 items of the Hamilton Depression Scale Covering the Continuum of Depressive Syndrome. Full Text available with Trip Pro

The Major Depressive Disorder Hierarchy: Rasch Analysis of 6 items of the Hamilton Depression Scale Covering the Continuum of Depressive Syndrome. Melancholic features of depression (MFD) seem to be a unidimensional group of signs and symptoms. However, little importance has been given to the evaluation of what features are related to a more severe disorder. That is, what are the MFD that appear only in the most depressed patients. We aim to demonstrate how each MFD is related to the severity (...) of the major depressive disorder.We evaluated both the Hamilton depression rating scale (HDRS-17) and its 6-item melancholic subscale (HAM-D6) in 291 depressed inpatients using Rasch analysis, which computes the severity of each MFD. Overall measures of model fit were mean (±SD) of items and persons residual = 0 (±1); low χ2 value; p>0.01.For the HDRS-17 model fit, mean (±SD) of item residuals = 0.35 (±1.4); mean (±SD) of person residuals = -0.15 (±1.09); χ2 = 309.74; p<0.00001. For the HAM-D6 model fit

2017 PLoS ONE

4. Hamilton Depression Scale

Depression Scale Aka: Hamilton Depression Scale , Ham-D II. Background Twenty one question Survey completed by physician III. Questions Depressed mood (0 to 4) Feelings of guilt (0 to 4) (0 to 4) Early (0 to 2) Middle (0 to 2) Late (0 to 2) Work activities (0 to 4) Retardation to stupor (0 to 4) (0 to 2) Fear (0 to 4) Anxiety (0 to 4) Gastrointestinal symptoms (0 to 2) Systemic somatic symptoms (0 to 2) Decreased libido or menstrual disturbance (0 to 2) (0 to 4) Weight loss (0 to 2) Diminished insight (0 (...) Hamilton Depression Scale Hamilton Depression Scale Toggle navigation Brain Head & Neck Chest Endocrine Abdomen Musculoskeletal Skin Infectious Disease Hematology & Oncology Cohorts Diagnostics Emergency Findings Procedures Prevention & Management Pharmacy Resuscitation Trauma Emergency Procedures Ultrasound Cardiovascular Emergencies Lung Emergencies Infectious Disease Pediatrics Neurologic Emergencies Skin Exposure Miscellaneous Abuse Cancer Administration 4 Hamilton Depression Scale Hamilton

2018 FP Notebook

5. The efficacy of paroxetine and placebo in treating anxiety and depression: a meta-analysis of change on the hamilton rating scales. Full Text available with Trip Pro

The efficacy of paroxetine and placebo in treating anxiety and depression: a meta-analysis of change on the hamilton rating scales. Previous meta-analyses of published and unpublished trials indicate that antidepressants provide modest benefits compared to placebo in the treatment of depression; some have argued that these benefits are not clinically significant. However, these meta-analyses were based only on trials submitted for the initial FDA approval of the medication and were limited (...) examined the data from all placebo-controlled, double-blind trials of paroxetine that included change scores on the Hamilton Rating Scale for Anxiety (HRSA) and/or the Hamilton Rating Scale for Depression (HRSD). For the treatment of anxiety (k = 12), the efficacy difference between paroxetine and placebo was modest (d = 0.27), and independent of baseline severity of anxiety. Overall change in placebo-treated individuals replicated 79% of the magnitude of paroxetine response. Efficacy was superior

2014 PloS one

6. Worsening Anxiety, Irritability, Insomnia, or Panic Predicts Poorer Antidepressant Treatment Outcomes: Clinical Utility and Validation of the Concise Associated Symptom Tracking (CAST) Scale Full Text available with Trip Pro

and overall worsening with remission was tested with logistic regression analyses.The 5-domain structure had adequate model fit on confirmatory factor analysis (GFI=0.93, CFI=0.89, and RMSEA=0.07). Scores on anxiety, panic, insomnia, and mania significantly correlated with Hamilton Rating Scale for Depression anxiety subscale (rs=0.27), Psychiatric Diagnostic Screening Questionnaire-panic scale (rs=0.35), sum of 3 Quick Inventory of Depressive Symptomatology Self-Report insomnia items (rs=0.55 (...) Worsening Anxiety, Irritability, Insomnia, or Panic Predicts Poorer Antidepressant Treatment Outcomes: Clinical Utility and Validation of the Concise Associated Symptom Tracking (CAST) Scale We report on the psychometric properties of the 16-item Concise Associated Symptom Tracking Scale self-report scale and its clinical utility.The 5-domain (irritability, anxiety, mania, insomnia, and panic) structure of Concise Associated Symptom Tracking Scale was validated with confirmatory factor analysis

2017 International Journal of Neuropsychopharmacology

7. Alpha-Stim AID for anxiety

, cranial electrotherapy stimulation; FDADS, four-dimensional anxiety and depression scale-anxiety subscale; GAD, generalised anxiety disorder; HAM-A, Hamilton Anxiety Rating Scale; HAM-D, Hamilton Depression Rating Scale; SAS, self-rating anxiety; SDS, self-rating depression; SD, standard deviation. Recent and ongoing studies CES in the treatment of post-traumatic stress disorder. ClinicalTrial.gov identifier: NCT 03757494. Status: recruiting. Indication: post-traumatic stress disorder. Intervention (...) . Intervention and comparator(s) Alpha-Stim SCS. No comparator. Key outcomes Mean HAM-A score decreased significantly from 21.25 (SD=5.82) at baseline to 12.67 (SD=5.47) the end of the study (6 weeks, p=0.01). Six patients (50%) had a 50% decrease on HAM-A and a score of 1 or 2 on the Clinical Global Impression – Improvement scale and GAD was considered to respond to treatment. The FDADS-anxiety subscale score reduced significantly from 30.58 (SD=11.24) at baseline to 23.83 (SD=7.57) at the end of the study

2019 National Institute for Health and Clinical Excellence - Advice

8. Mental Health: Universal School-Based Cognitive Behavioral Therapy Programs to Reduce Depression and Anxiety Symptoms

Depression Inventory. Anxiety symptoms were most frequently measured with the Spence Children’s Anxiety Scale, followed by the Multidimensional Anxiety Scale for Children. The included studies from the United States targeted adolescents (10-17 years), and were delivered by external mental health professionals (6 studies) or trained school staff (2 studies). Study populations represented a range of racial and ethnic groups. Supporting Materials Analytic Framework [PDF - 478 kB] Summary Evidence Table (...) , Ollendick TH. Prevention of anxiety symptoms in children: results from a universal school-based trial. Behavior Therapy 2012;43:450–64. Garaigordobil M. Effects of a psychological intervention on factors of emotional development during adolescence. European Journal of Psychological Assessment 2004;20:66. Gillham JE, Hamilton J, Freres DR, Patton K, Gallop R. Preventing depression among early adolescents in the primary care setting: A randomized controlled study of the Penn Resiliency Program. Journal

2020 Community Preventive Services Task Force

9. Hamilton Anxiety Scale

Hamilton Anxiety Scale Hamilton Anxiety Scale Toggle navigation Brain Head & Neck Chest Endocrine Abdomen Musculoskeletal Skin Infectious Disease Hematology & Oncology Cohorts Diagnostics Emergency Findings Procedures Prevention & Management Pharmacy Resuscitation Trauma Emergency Procedures Ultrasound Cardiovascular Emergencies Lung Emergencies Infectious Disease Pediatrics Neurologic Emergencies Skin Exposure Miscellaneous Abuse Cancer Administration 4 Hamilton Anxiety Scale Hamilton Anxiety (...) Scale Aka: Hamilton Anxiety Scale , HAM-A II. Background Authored by Max Hamilton in 1959 Public domain anxiety rating scale III. Criteria: Symptom Rating Scale (0=Not Present, 4=Disabling) Anxious Mood Worries Anticipates worst Tension Startles Cries easily Restless Trembling Fears Fear of the dark Fear of strangers Fear of being alone Fear of animal Difficulty falling asleep or staying asleep Difficulty with s Intellectual Poor concentration Memory Depressed Mood Decreased interest in activities

2015 FP Notebook

10. Systematic Review - Relationship of Deployment-related Mild Traumatic Brain Injury to Posttraumatic Stress Disorder, Depressive Disorders, Substance Use Disorders, Suicidal Ideation, and Anxiety Disorders

Depression CPT Cognitive Processing Therapy CTBIE Comprehensive Traumatic Brain Injury Evaluation DoD Department of Defense DSM-IV Diagnostic and Statistical Manual of Mental Disorders, 4 th edition DVBIC Defense and Veterans Brain Injury Center ES Effect size HAM-A Hamilton Anxiety Rating Scale HBO2 Hyperbaric Oxygen Therapy HSR&D Health Services Research & Development ICD International Classification of Diseases ISS Injury Severity Score LOC Loss of consciousness MADRS Montgomery-Asberg Depression (...) Acceptance and Commitment Therapy AIS Abbreviated Injury Scale AOC Alteration of consciousness AS Altered state AUDIT-(C) Alcohol Use Disorders Identification Test-(Consumption) BAI Beck Anxiety Inventory BDI Beck Depression Inventory BHM Behavioral Health Measure BSI Brief Symptom Inventory CAGE Cutting down, Annoyance by criticism, Guilty feeling, and Eye openers CAPS (CAPS- IV) Clinician Administered PTSD Scale (CAPS for DSM-IV) CCT Controlled clinical trial CESD Center for Epidemiologic Studies

2019 Veterans Affairs Evidence-based Synthesis Program Reports

11. Interventions for treating anxiety after stroke. Full Text available with Trip Pro

= 0.926, P value = 0.001; 19 participants analysed).The second trial randomised 81 participants with co-morbid anxiety and depression to paroxetine, paroxetine plus psychotherapy, or standard care. Mean levels of anxiety severity scores based on the Hamilton Anxiety Scale (HAM-A) at follow-up were 5.4 (SD ± 1.7), 3.8 (SD ± 1.8), and 12.8 (SD ± 1.9), respectively (P value < 0.01).The third trial randomised 94 stroke patients, also with co-morbid anxiety and depression, to receive buspirone (...) included three trials (four interventions) involving 196 participants with stroke and co-morbid anxiety. One trial (described as a 'pilot study') randomised 21 community-dwelling stroke survivors to four-week use of a relaxation CD or to wait list control. This trial assessed anxiety using the Hospital Anxiety and Depression Scale and reported a reduction in anxiety at three months among participants who had used the relaxation CD (mean (standard deviation (SD) 6.9 (± 4.9) and 11.0 (± 3.9)), Cohen's d

2017 Cochrane

12. The Parkinson Anxiety Scale (PAS): Development and validation of a new anxiety scale. Full Text available with Trip Pro

analysis and a Rasch analysis of items of the Hamilton Anxiety Rating Scale (HARS) and the Beck Anxiety Inventory (BAI) from a previously published study. Validation was done in a cross-sectional international multicenter study involving 362 patients with idiopathic PD. Patients underwent a single screening session in which the PAS was administered, along with the Hamilton Depression Rating Scale, the HARS, and the BAI. The Mini International Neuropsychiatric Interview was administered to establish (...) The Parkinson Anxiety Scale (PAS): Development and validation of a new anxiety scale. Existing anxiety rating scales have limited construct validity in patients with Parkinson's disease (PD). This study was undertaken to develop and validate a new anxiety rating scale, the Parkinson Anxiety Scale (PAS), that would overcome the limitations of existing scales. The general structure of the PAS was based on the outcome of a Delphi procedure. Item selection was based on a canonical correlation

2014 Movement Disorders

13. On the Differential Diagnosis of Anxious from Nonanxious Major Depression by means of the Hamilton Scales Full Text available with Trip Pro

On the Differential Diagnosis of Anxious from Nonanxious Major Depression by means of the Hamilton Scales Anxious major depressive disorder (A-MDD) is differentially diagnosed from nonanxious MDD (NA-MDD) as MDD with a cut-off score ≥ 7 on the HAM-D anxiety-somatization factor (ASF). We investigated whether additional HAM-D items discriminate A-MDD from NA-MDD. Moreover, we tested the validity of ASF criterion against HAM-A, gold standard of anxiety severity assessment.164 consecutive female (...) middle-aged inpatients, diagnosed as A-MDD (n = 92) or NA-MDD (n = 72) by the normative HAM-A score for moderate-to-severe anxiety (≥ 25), were compared regarding 17-item HAM-D scores. The validity of ASF ≥ 7 criterion was assessed by receiver-operating characteristics (ROC) analysis.We found medium and large effect size differences between A-MDD and NA-MDD patients in only four out of the six ASF items, as well as in three further HAM-D items, namely, those of agitation, middle insomnia, and delayed

2013 The Scientific World Journal

14. Does the Geriatric Depression Scale measure depression in Parkinson's disease? Full Text available with Trip Pro

the GDS-30, and items were subjected to a principle component analysis. Geriatric Depression Scale total and factor scores were correlated with depression items from the Movement Disorder Society Unified Parkinson's disease Rating Scale (MDS-UPDRSd) and Hamilton Rating Scale for Depression (HAMDd), as well as with the Apathy Scale (AS), State-Trait Anxiety Inventory (STAI), Modified Fatigue Impact Scale (MFIS), Parkinson's disease Sleep Scale, and a Subjective Cognitive Function composite score.The (...) Does the Geriatric Depression Scale measure depression in Parkinson's disease? The Geriatric Depression Scale (GDS) is recommended for screening depression in individuals with Parkinson's disease (PD). Empirical evidence, however, is limited regarding its validity and factor structure in PD. Thus, the current study sought to evaluate the convergent and divergent validity of the GDS, as well as the structure and validity of the derived factors.Nondemented individuals with PD (n = 158) completed

2018 International Journal of Geriatric Psychiatry

15. Mapping depression rating scale phenotypes onto research domain criteria (RDoC) to inform biological research in mood disorders. Full Text available with Trip Pro

approximating RDoC criteria.Using expert review and consensus, we defined four major depression phenotypes based on specific RDoC constructs. Having matched these constructs to individual items from the Hamilton Depression Rating Scale and Quick Inventory of Depressive Symptomatology, we identified subjects meeting criteria for each of these phenotypes from two large clinical trials of patients treated for major depression. In a post hoc analysis, we evaluated the overall treatment response based (...) Mapping depression rating scale phenotypes onto research domain criteria (RDoC) to inform biological research in mood disorders. Substantial research progress can be achieved if available clinical datasets can be mapped to the National Institute of Mental Health Research-Domain-Criteria (RDoC) constructs. This mapping would allow investigators to both explore more narrowly defined clinical phenotypes and the relationship of these phenotypes to biological markers and clinical outcomes

2018 Journal of Affective Disorders

16. A Study to Evaluate Scales for Repetitive and Restricted Behaviors in Children, Adolescents, and Adults With Autism Spectrum Disorder (ASD)

Frame: Baseline until study completion (approximately 12 weeks) ] Hamilton Anxiety Rating Scale (HAM-A) [ Time Frame: Baseline until study completion (approximately 12 weeks) ] Parent Rated Anxiety Scale for ASD (PRAS-ASD) [ Time Frame: Baseline until study completion (approximately 12 weeks) ] Beck Anxiety Index (BAI) [ Time Frame: Baseline until study completion (approximately 12 weeks) ] Digital Biomarkers [ Time Frame: Baseline until study completion (approximately 12 weeks) ] Participants (...) A Study to Evaluate Scales for Repetitive and Restricted Behaviors in Children, Adolescents, and Adults With Autism Spectrum Disorder (ASD) A Study to Evaluate Scales for Repetitive and Restricted Behaviors in Children, Adolescents, and Adults With Autism Spectrum Disorder (ASD) - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study

2018 Clinical Trials

17. Hamilton Depression Scale

Depression Scale Aka: Hamilton Depression Scale , Ham-D II. Background Twenty one question Survey completed by physician III. Questions Depressed mood (0 to 4) Feelings of guilt (0 to 4) (0 to 4) Early (0 to 2) Middle (0 to 2) Late (0 to 2) Work activities (0 to 4) Retardation to stupor (0 to 4) (0 to 2) Fear (0 to 4) Anxiety (0 to 4) Gastrointestinal symptoms (0 to 2) Systemic somatic symptoms (0 to 2) Decreased libido or menstrual disturbance (0 to 2) (0 to 4) Weight loss (0 to 2) Diminished insight (0 (...) Hamilton Depression Scale Hamilton Depression Scale Toggle navigation Brain Head & Neck Chest Endocrine Abdomen Musculoskeletal Skin Infectious Disease Hematology & Oncology Cohorts Diagnostics Emergency Findings Procedures Prevention & Management Pharmacy Resuscitation Trauma Emergency Procedures Ultrasound Cardiovascular Emergencies Lung Emergencies Infectious Disease Pediatrics Neurologic Emergencies Skin Exposure Miscellaneous Abuse Cancer Administration 4 Hamilton Depression Scale Hamilton

2015 FP Notebook

18. Why do some depressed outpatients who are in remission according to the Hamilton Depression Rating Scale not consider themselves to be in remission? (Abstract)

Why do some depressed outpatients who are in remission according to the Hamilton Depression Rating Scale not consider themselves to be in remission? In treatment studies of depression, remission is typically defined narrowly, based on scores on symptom severity scales. Patients treated in clinical practice, however, define the concept of remission more broadly and consider functional status, coping ability, and life satisfaction as important indicators of remission status. In the present report (...) from the Rhode Island Methods to Improve Diagnostic Assessment and Services project, we examined how many depressed patients in ongoing treatment who scored in the remission range on the 17-item Hamilton Depression Rating scale (HDRS) did not consider themselves to be in remission from their depression. Among the HDRS remitters, we compared the demographic and clinical characteristics of patients who did and did not consider themselves to be in remission.From March 2009 to July 2010, we interviewed

2012 Journal of Clinical Psychiatry

19. Pharmacological treatments for generalised anxiety disorder: a systematic review and network meta-analysis. Full Text available with Trip Pro

on randomised trials in adult outpatients with generalised anxiety disorder identified from MEDLINE, Web of Science, Cochrane Library, ClinicalTrials.gov, Chinese National Knowledge Infrastructure (CNKI), Wanfang data, Drugs@FDA and commercial pharmaceutical registries. Placebo and active control trials were included. Data were extracted from all manuscripts and reports. Primary outcomes were efficacy (mean difference [MD] in change in Hamilton Anxiety Scale Score) and acceptability (study discontinuations (...) Pharmacological treatments for generalised anxiety disorder: a systematic review and network meta-analysis. Generalised anxiety disorder is a disease that can be associated with substantial dysfunction. Pharmacological treatment is often the first choice for clinicians because of the cost and resource constraints of psychological alternatives, but there is a paucity of comparative information for the multiple available drug choices.A systematic review and network meta-analysis was performed

2019 Lancet

20. Generalised anxiety disorder: quetiapine

doses on rates of GAD response or remission compared with placebo, measured by the Hamilton Anxiety Rating Scale (HAM-A). However, the RCTs found no statistically significant Generalised anxiety disorder: quetiapine (ESUOM12) © NICE 2018. All rights reserved. Subject to Notice of rights (https://www.nice.org.uk/terms-and- conditions#notice-of-rights). Page 4 of 29difference in rates of response or remission between prolonged-release quetiapine and either paroxetine or escitalopram, although they may (...) =0.61 Non-remission b n=213 n=207 Risk ratio 0.97 (95% CI 0.85 to 1.09), p=0.18 Discontinuation because of adverse events c n=213 n=206 Risk ratio 0.39 (95% CI 0.24 to 0.62), p=0.0001 Abbreviations: CI, confidence interval; RCT, randomised controlled trial. a Non-response was defined as a reduction in Hamilton Anxiety Rating Scale (HAM-A) score of 7. A risk ratio 0.3 Secondary outcomes HAM-A remission rate at week 8 b 36.4% (4/11) 18.2% (2/11) p=0.635 Clinical response at week 8 d 54% (6/11) 45% (5

2013 National Institute for Health and Clinical Excellence - Advice

To help you find the content you need quickly, you can filter your results via the categories on the right-hand side >>>>